Strategic evaluation of pricing and reimbursement
Pricing and Reimbursement: Knowing Your Value up Front is Key to Future Dealmaking
Scientia Advisors' Patrick Terry, Principal, is featured in partneringNEWS --June 14, 2011 issue-- with an article titled "Pricing and Reimbursement: Knowing you value up front is key to future dealmaking."
As a result of today's evolving healthcare market, a new strategy is needed to evaluate pricing and reimbursement. Companies must determine viability in the market to ensure that their life science ventures will not fail. Such ventures must be scrutinized with realistic, fact-based information at the early stages of the product development cycle for their impact on payers' top and bottom lines in terms of:
- Factors of market access
- Pricing
- Reimbursement challenges
In this article, Patrick Terry presents a clear and practical approach that life science companies should take and concludes that a full understanding of one's value proposition will prevent situations from occurring in which potential partners drop out of a deal based on poor evaluations.
This article can be accessed on the parteneringNEWS website here.
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
